Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with verticals in industries, including artificial intelligence, machine learning, and healthcare. Its products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and dark Web, making predictive analytics. This platform provides insights into market trends and direct customer feedback. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amount of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform.


TSXV:DM - Post by User

Comment by MUTDMUTDon Aug 26, 2022 10:33am
78 Views
Post# 34922361

RE:RE:RE:The News Release

RE:RE:RE:The News Release...so that title could be deemed as accurate but should have further clarified as follows...IN THE SECOND QUARTER DATAMETREX REPORTS OVER $18.3M REVENUE FOR FIRST 6 MONTHS 2022... where the reference to Q2 is stating when the statement was made and the revenue value is stating when the revs were made... having reviewed the actual NR I don't believe that it is technically inaccurate, but I think the title could have been better worded as noted here... I would not have worded it that way but if you read the entire NR it is truthful and accurate IMO... DYODD...
Pandora wrote:
swyint123888 wrote: I emailed the company to remove the misleading NR and restate it.....I hope they do it on their own before the governing bodies make them do it.....this is pathetic to say the least.....asking 9 now......do you think serious real investors are going to stand for these childesh games.....18.3 million what a joke




It's all in how you frame it. Stockwatch got the same news and issued it this way:

 

Datametrex AI loses $1.35-million in Q2 2022

 

2022-08-26 09:26 ET - News Release

 

Mr. Marshall Gunter reports

DATAMETREX REPORTS OVER $18.3M REVENUE IN THE SECOND QUARTER

Datametrex AI Ltd. has released its financial results for the second quarter. Datametrex has filed on SEDAR its financial statements and related management discussion and analysis (MD&A) for the quarterly results ending June 30, 2022 (Q2 2022).

Q1 2022 financial summary

The company's financial performance experienced a significant increase in its IT services revenue and is currently working with several companies to expand and grow its AI (artificial intelligence) and technology sectors.

The company reported revenue of over $18-million, earnings before interest, taxes, depreciation and amortization (EBITDA) of $1,431,035 and adjusted EBITDA of $3,265,906 for six months ended June 30, 2022. The company bared a non-cash expense of $1,834,871 for option issuance and depreciation and amortization of $1,255,173. Management believes adjusted EBITDA, $3,265,906, is the true reflection of operations within the last six months. The cash balance remains strong. The company used $934,116 to exercise the normal course issuer bid to increase return to the company's shareholders.

"Our 2022 second quarter results reflect a strong increase in our IT services as we expand our core AI and IT services to companies globally. We look forward to further expanding these services through MediCall and DMEVS. We are proud to be one of the small cap stocks to maintain a strong cash balance and are thrilled to see our share buy back program gain traction," said Marshall Gunter, chief executive officer of the company.

The following financial information from the financial results ending June 30, 2022, and management discussion and analysis are available for review on SEDAR.

Please refer to the Q2 2022 filing in its entirety, which is available under Datametrex's profile at SEDAR.





<< Previous
Bullboard Posts
Next >>